Immediate Impact
22 standout
Citing Papers
Myasthenia gravis: the changing treatment landscape in the era of molecular therapies
2024 Standout
Non-coding RNAs in human health and disease: potential function as biomarkers and therapeutic targets
2023 Standout
Works of Marina Dusl being referenced
A 3'-UTR mutation creates a microRNA target site in the GFPT1 gene of patients with congenital myasthenic syndrome
2015
Salbutamol-responsive limb-girdle congenital myasthenic syndrome due to a novel missense mutation and heteroallelic deletion in MUSK
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Marina Dusl | 215 | 135 | 125 | 10 | 308 | |
| Amina Chaouch | 184 | 143 | 113 | 13 | 307 | |
| Daniel Lashley | 235 | 122 | 92 | 13 | 321 | |
| Nicola Carboni | 68 | 175 | 60 | 13 | 310 | |
| Shen-Long Howng | 48 | 143 | 81 | 13 | 335 | |
| Meritxell B. Cutrona | 75 | 115 | 69 | 10 | 272 | |
| Eric D. de Groh | 72 | 204 | 95 | 9 | 335 | |
| Thomas L. Hilder | 148 | 166 | 51 | 7 | 352 | |
| Alexandre Nagel | 227 | 240 | 97 | 9 | 366 | |
| Grace McMacken | 101 | 156 | 53 | 11 | 293 | |
| Denise Griffiths | 85 | 143 | 49 | 8 | 337 |
All Works
Login with ORCID to disown or claim papers
Loading papers...